Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gruaz-Guyon, A; Janevik-Ivanovska, E; Raguin, O; De Labriolle-Vaylet, C; Barbet, J
   Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy
   QUARTERLY JOURNAL OF NUCLEAR MEDICINE
   
   A. Gruaz-Guyon et al., "Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy", Q J NUCL M, 45(2), 2001, pp. 201-206
2. Gestin, JF; Loussouarn, A; Bardies, M; Gautherot, E; Gruaz-Guyon, A; Sai-Maurel, C; Barbet, J; Curtet, C; Chatal, JF; Faivre-Chauvet, A
   Two-step targeting of xenografted colon carcinoma using a bispecific antibody and Re-188-labeled bivalent hapten: Biodistribution and dosimetry studies
   JOURNAL OF NUCLEAR MEDICINE
   
   J.F. Gestin et al., "Two-step targeting of xenografted colon carcinoma using a bispecific antibody and Re-188-labeled bivalent hapten: Biodistribution and dosimetry studies", J NUCL MED, 42(1), 2001, pp. 146-153
3. Tran, A; Treluyer, JM; Rey, E; Barbet, J; Ferracci, G; d'Athis, P; Vincent, J; Pons, G
   Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat
   TOXICOLOGY AND APPLIED PHARMACOLOGY
   
   A. Tran et al., "Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat", TOX APPL PH, 170(3), 2001, pp. 145-152
4. de Labriolle-Vaylet, C; Cattan, P; Sarfati, E; Wioland, M; Billotey, C; Brocheriou, C; Rouvier, E; de Roquancourt, A; Rostene, W; Askienazy, S; Barbet, J; Milhaud, G; Gruaz-Guyon, A
   Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery
   CLINICAL CANCER RESEARCH
   
   C. de Labriolle-Vaylet et al., "Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery", CLIN CANC R, 6(2), 2000, pp. 363-371
5. Karacay, H; McBride, WJ; Griffiths, GL; Sharkey, RM; Barbet, J; Hansen, HJ; Goldenberg, DM
   Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a Tc-99m-Re-188-labeled peptide
   BIOCONJUGATE CHEMISTRY
   
   H. Karacay et al., "Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a Tc-99m-Re-188-labeled peptide", BIOCONJ CHE, 11(6), 2000, pp. 842-854
6. de Boisferon, MH; Raguin, O; Dussaillant, M; Rostene, W; Barbet, J; Gruaz-Guyon, A
   Enhanced targeting specificity to tumor cells by simultaneous recognition of two antigens
   BIOCONJUGATE CHEMISTRY
   
   M.H. de Boisferon et al., "Enhanced targeting specificity to tumor cells by simultaneous recognition of two antigens", BIOCONJ CHE, 11(4), 2000, pp. 452-460
7. Hosono, MN; Hosono, M; Mishra, AK; Faivre-Chauvet, A; Gautherot, E; Barbet, J; Knapp, FF; Chatal, JF
   Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer
   ANNALS OF NUCLEAR MEDICINE
   
   M.N. Hosono et al., "Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer", ANN NUCL M, 14(3), 2000, pp. 173-179
8. Gautherot, E; Rouvier, E; Daniel, L; Loucif, E; Bouhou, J; Manetti, C; Martin, M; Le Doussal, JM; Barbet, J
   Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and I-131-labeled bivalent hapten
   JOURNAL OF NUCLEAR MEDICINE
   
   E. Gautherot et al., "Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and I-131-labeled bivalent hapten", J NUCL MED, 41(3), 2000, pp. 480-487
9. Pelegrin, A; Xavier, F; Barbet, J; Bartholeyns, J; Baty, D; Buchegger, F; Chatal, JF; Dubief, F; Guerreau, D; Gruaz-Guyon, A; Lamotte, D; Leserman, L; Mach, JP; Robert, B; Saccavini, JC; Teillaud, JL; Teulon, I
   Immunotargeting of tumors: state of the art and prospects in 2000
   BULLETIN DU CANCER
   
   A. Pelegrin et al., "Immunotargeting of tumors: state of the art and prospects in 2000", B CANCER, 87(11), 2000, pp. 777-791
10. Barbet, J; Kraeber-Bodere, F; Vuillez, JP; Gautherot, E; Rouvier, R; Chatal, JF
    Pretargeting with the Affinity Enhancement System for radioimmunotherapy
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    J. Barbet et al., "Pretargeting with the Affinity Enhancement System for radioimmunotherapy", CANC BIO R, 14(3), 1999, pp. 153-166
11. Gautherot, E; Kraeber-Bodere, F; Daniel, L; Fiche, M; Rouvier, E; Sai-Maurel, C; Thedrez, P; Chatal, JF; Barbet, J
    Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody
    CLINICAL CANCER RESEARCH
    
    E. Gautherot et al., "Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody", CLIN CANC R, 5(10), 1999, pp. 3177S-3182S
12. Kraeber-Bodere, F; Faivre-Chauvet, A; Sai-Maurel, C; Campion, L; Fiche, M; Gautherot, E; Le Boterff, J; Barbet, J; Chatal, JF; Thedrez, P
    Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections
    CLINICAL CANCER RESEARCH
    
    F. Kraeber-Bodere et al., "Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections", CLIN CANC R, 5(10), 1999, pp. 3183S-3189S
13. Kraeber-Bodere, F; Bardet, S; Hoefnagel, CA; Vieira, MR; Vuillez, JP; Murat, A; Ferreira, TC; Bardies, M; Ferrer, L; Resche, I; Gautherot, E; Rouvier, E; Barbet, J; Chatal, JF
    Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial
    CLINICAL CANCER RESEARCH
    
    F. Kraeber-Bodere et al., "Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial", CLIN CANC R, 5(10), 1999, pp. 3190S-3198S
14. Vuillez, JP; Kraeber-Bodere, F; Moro, D; Bardies, M; Douillard, JY; Gautherot, E; Rouvier, E; Barbet, J; Garban, F; Moreau, P; Chatal, JF
    Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial
    CLINICAL CANCER RESEARCH
    
    J.P. Vuillez et al., "Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial", CLIN CANC R, 5(10), 1999, pp. 3259S-3267S
15. Hosono, M; Hosono, MN; Kraeber-Bodere, F; Devys, A; Thedrez, P; Faivre-Chauvet, A; Gautherot, E; Barbet, J; Chatal, JF
    Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten
    JOURNAL OF NUCLEAR MEDICINE
    
    M. Hosono et al., "Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten", J NUCL MED, 40(7), 1999, pp. 1216-1221
16. Kraeber-Bodere, F; Faivre-Chauvet, A; Sai-Maurel, C; Gautherot, E; Fiche, M; Campion, L; Le Boterff, J; Barbet, J; Chatal, JF; Thedrez, P
    Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft
    JOURNAL OF NUCLEAR MEDICINE
    
    F. Kraeber-Bodere et al., "Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft", J NUCL MED, 40(1), 1999, pp. 198-204
17. HOSONO M; HOSONO MN; KRAEBERBODERE F; DEVYS A; THEDREZ P; FICHE M; GAUTHEROT E; BARBET J; CHATAL JF
    BIODISTRIBUTION AND DOSIMETRIC STUDY IN MEDULLARY-THYROID CANCER XENOGRAFT USING BISPECIFIC ANTIBODY AND IODINE-125-LABELED BIVALENT HAPTEN
    The Journal of nuclear medicine
    
    M. Hosono et al., "BIODISTRIBUTION AND DOSIMETRIC STUDY IN MEDULLARY-THYROID CANCER XENOGRAFT USING BISPECIFIC ANTIBODY AND IODINE-125-LABELED BIVALENT HAPTEN", The Journal of nuclear medicine, 39(9), 1998, pp. 1608-1613
18. BARBET J; PELTIER P; BARDET S; VUILLEZ JP; BACHELOT I; DENET S; OLIVIER P; LECCIA F; CORCUFF B; HUGLO D; PROYE C; ROUVIER E; MEYER P; CHATAL JF
    RADIOIMMUNODETECTION OF MEDULLARY-THYROID CARCINOMA USING IN-111 BIVALENT HAPTEN AND ANTI-CEA X ANTI-DTPA-INDIUM BISPECIFIC ANTIBODY
    The Journal of nuclear medicine
    
    J. Barbet et al., "RADIOIMMUNODETECTION OF MEDULLARY-THYROID CARCINOMA USING IN-111 BIVALENT HAPTEN AND ANTI-CEA X ANTI-DTPA-INDIUM BISPECIFIC ANTIBODY", The Journal of nuclear medicine, 39(7), 1998, pp. 1172-1178
19. VUILLEZ JP; MORO D; BODERE F; CURRAT C; MEYER P; BRAMBILLA C; CHATAL JF; BARBET J; FAGRET D
    RADIOIMMUNOTHERAPY OF SMALL-CELL LUNG-CARCINOMA WITH THE 2-STEP METHOD USING A BISPECIFIC ANTI-CEA ANTI-DTPA ANTIBODY AND THE I-131 DI-DTPAHAPTEN - PRELIMINARY-RESULTS/
    The Journal of nuclear medicine
    
    J.P. Vuillez et al., "RADIOIMMUNOTHERAPY OF SMALL-CELL LUNG-CARCINOMA WITH THE 2-STEP METHOD USING A BISPECIFIC ANTI-CEA ANTI-DTPA ANTIBODY AND THE I-131 DI-DTPAHAPTEN - PRELIMINARY-RESULTS/", The Journal of nuclear medicine, 39(5), 1998, pp. 271-271
20. BODERE FK; BARDET S; VUILLEZ JP; BARDIES M; GAUTHEROT E; ROUVIER E; BARBET J; CHATAL JF
    PHASE I II TRIAL OF 2-STEP RADIOIMMUNOTHERAPY IN MEDULLARY-THYROID CANCER (MTC) USING BISPECIFIC ANTI-CEA/ANTI-DTPA-IN ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN/
    The Journal of nuclear medicine
    
    F.K. Bodere et al., "PHASE I II TRIAL OF 2-STEP RADIOIMMUNOTHERAPY IN MEDULLARY-THYROID CANCER (MTC) USING BISPECIFIC ANTI-CEA/ANTI-DTPA-IN ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN/", The Journal of nuclear medicine, 39(5), 1998, pp. 1084-1084
21. GAUTHEROT E; LEDOUSSAL JM; BOUHOU J; MANETTI C; MARTIN M; ROUVIER E; BARBET J
    DELIVERY OF THERAPEUTIC DOSES OF RADIOIODINE USING BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS
    The Journal of nuclear medicine
    
    E. Gautherot et al., "DELIVERY OF THERAPEUTIC DOSES OF RADIOIODINE USING BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS", The Journal of nuclear medicine, 39(11), 1998, pp. 1937-1943
22. SERRE K; MACHY P; GRIVEL JC; JOLLY G; BRUN N; BARBET J; LESERMAN L
    EFFICIENT PRESENTATION OF MULTIVALENT ANTIGENS TARGETED TO VARIOUS CELL-SURFACE MOLECULES OF DENDRITIC CELLS AND SURFACE IG OF ANTIGEN-SPECIFIC B-CELLS
    The Journal of immunology (1950)
    
    K. Serre et al., "EFFICIENT PRESENTATION OF MULTIVALENT ANTIGENS TARGETED TO VARIOUS CELL-SURFACE MOLECULES OF DENDRITIC CELLS AND SURFACE IG OF ANTIGEN-SPECIFIC B-CELLS", The Journal of immunology (1950), 161(11), 1998, pp. 6059-6067
23. JANEVIKIVANOVSKA E; GAUTHEROT E; DEBOISFERON MH; COHEN M; MILHAUD G; TARTAR A; ROSTENE W; BARBET J; GRUAZGUYON A
    BIVALENT HAPTEN-BEARING PEPTIDES DESIGNED FOR I-131 PRETARGETED RADIOIMMUNOTHERAPY
    Bioconjugate chemistry
    
    E. Janevikivanovska et al., "BIVALENT HAPTEN-BEARING PEPTIDES DESIGNED FOR I-131 PRETARGETED RADIOIMMUNOTHERAPY", Bioconjugate chemistry, 8(4), 1997, pp. 526-533
24. ROUVIER E; GAUTHEROT E; MEYER P; BARBET J
    TARGETING MEDULLARY-THYROID CARCINOMAS WITH BISPECIFIC ANTIBODIES ANDBIVALENT HAPTENS - RESULTS AND CLINICAL PERSPECTIVES
    Hormone research
    
    E. Rouvier et al., "TARGETING MEDULLARY-THYROID CARCINOMAS WITH BISPECIFIC ANTIBODIES ANDBIVALENT HAPTENS - RESULTS AND CLINICAL PERSPECTIVES", Hormone research, 47(4-6), 1997, pp. 163-167
25. GAUTHEROT E; BOUHOU J; LOUCIF E; MANETTI C; MARTIN M; LEDOUSSAL JW; ROUVIER E; BARBET J
    RADIOIMMUNOTHERAPY OF LS174T COLON-CARCINOMA IN NUDE-MICE USING AN IODINE-131-LABELED BIVALENT HAPTEN COMBINED WITH AN ANTI-CEA X ANTI-INDIUM-DTPA BISPECIFIC ANTIBODY
    The Journal of nuclear medicine
    
    E. Gautherot et al., "RADIOIMMUNOTHERAPY OF LS174T COLON-CARCINOMA IN NUDE-MICE USING AN IODINE-131-LABELED BIVALENT HAPTEN COMBINED WITH AN ANTI-CEA X ANTI-INDIUM-DTPA BISPECIFIC ANTIBODY", The Journal of nuclear medicine, 38(5), 1997, pp. 18-18
26. KRAEBERBODERE F; FAIVRECHAUVET A; SAIMAUREL C; LEBOTERFF J; GAUTHEROT E; BARBET J; CHATAL JF; THEDREZ P
    RADIOIMMUNOTHERAPY (RIT) WITH BISPECIFIC ANTIBODY AND I-131-LABELED BIVALENT HAPTEN IN NUDE-MICE BEARING A HUMAN MEDULLARY-THYROID CARCINOMA (MTC)
    The Journal of nuclear medicine
    
    F. Kraeberbodere et al., "RADIOIMMUNOTHERAPY (RIT) WITH BISPECIFIC ANTIBODY AND I-131-LABELED BIVALENT HAPTEN IN NUDE-MICE BEARING A HUMAN MEDULLARY-THYROID CARCINOMA (MTC)", The Journal of nuclear medicine, 38(5), 1997, pp. 105-105
27. VUILLEZ JP; MORO D; BRICHON PY; ROUVIER E; BRAMBILLA E; BARBET J; PELTIER P; MEYER P; SARRAZIN R; BRAMBILLA C
    2-STEP IMMUNOSCINTIGRAPHY FOR NON-SMALL-CELL LUNG-CANCER STAGING USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER/
    The Journal of nuclear medicine
    
    J.P. Vuillez et al., "2-STEP IMMUNOSCINTIGRAPHY FOR NON-SMALL-CELL LUNG-CANCER STAGING USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER/", The Journal of nuclear medicine, 38(4), 1997, pp. 507-511
28. MANETTI C; ROUVIER E; GAUTHEROT E; LOUCIF E; BARBET J; LEDOUSSAL JM
    TARGETING BCL1 LYMPHOMA WITH ANTIIDIOTYPE ANTIBODIES - BIODISTRIBUTION KINETICS OF DIRECTLY LABELED ANTIBODIES AND BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS
    International journal of cancer
    
    C. Manetti et al., "TARGETING BCL1 LYMPHOMA WITH ANTIIDIOTYPE ANTIBODIES - BIODISTRIBUTION KINETICS OF DIRECTLY LABELED ANTIBODIES AND BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS", International journal of cancer, 71(6), 1997, pp. 1000-1009
29. GAUTHEROT E; BOUHOU J; LEDOUSSAL JM; MANETTI C; MARTIN M; ROUVIER E; BARBET J
    THERAPY FOR COLON-CARCINOMA XENOGRAFTS WITH BISPECIFIC ANTIBODY-TARGETED, IODINE-131-LABELED BIVALENT HAPTEN
    Cancer
    
    E. Gautherot et al., "THERAPY FOR COLON-CARCINOMA XENOGRAFTS WITH BISPECIFIC ANTIBODY-TARGETED, IODINE-131-LABELED BIVALENT HAPTEN", Cancer, 80(12), 1997, pp. 2618-2623
30. THIMONIER J; MONTIXI C; CHAUVIN JP; HE HT; ROCCASERRA J; BARBET J
    THY-1 IMMUNOLABELED THYMOCYTE MICRODOMAINS STUDIES WITH THE ATOMIC-FORCE MICROSCOPE AND THE ELECTRON-MICROSCOPE
    Biophysical journal
    
    J. Thimonier et al., "THY-1 IMMUNOLABELED THYMOCYTE MICRODOMAINS STUDIES WITH THE ATOMIC-FORCE MICROSCOPE AND THE ELECTRON-MICROSCOPE", Biophysical journal, 73(3), 1997, pp. 1627-1632
31. MANETTI C; ROUVIER E; GAUTHEROT E; LOUCIF E; LEDOUSSAL JM; MARTIN M; BARBET J
    RADIOIMMUNOTHERAPY OF BCL1 LYMPHOMA WITH BISPECIFIC ANTIBODIES AND IODINE-131-LABELED BIVALENT HAPTENS
    The Journal of nuclear medicine
    
    C. Manetti et al., "RADIOIMMUNOTHERAPY OF BCL1 LYMPHOMA WITH BISPECIFIC ANTIBODIES AND IODINE-131-LABELED BIVALENT HAPTENS", The Journal of nuclear medicine, 37(5), 1996, pp. 505-505
32. BARDIES M; BARDET S; FAIVRECHAUVET A; PELTIER P; DOUILLARD JY; MAHE M; FICHE M; LISBONA A; GIACALONE F; MEYER P; GAUTHEROT E; ROUVIER E; BARBET J; CHATAL JF
    BISPECIFIC ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN DOSIMETRY IN PATIENTS WITH MEDULLARY-THYROID OR SMALL-CELL LUNG-CANCER
    The Journal of nuclear medicine
    
    M. Bardies et al., "BISPECIFIC ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN DOSIMETRY IN PATIENTS WITH MEDULLARY-THYROID OR SMALL-CELL LUNG-CANCER", The Journal of nuclear medicine, 37(11), 1996, pp. 1853-1859
33. MARANINCHI D; BARBET J; BATTAIS J; EMILIE D; GOEHRS JM; GUINOT P; MANNONI P; MEYER P; ROMETLEMONNE JL; TROUVIN JH; CALVO F; GALANAUD P; GOUYETTE A; JULOU CL; MARCEL T; MOREL A; QUENTINMILLET MJ; SCHATZ C; WIJDENES J
    WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN
    Therapie
    
    D. Maraninchi et al., "WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN", Therapie, 51(4), 1996, pp. 431-433
34. DEVYS A; THEDREZ P; GAUTHEROT E; FAIVRECHAUVET A; SAIMAUREL C; ROUVIER E; AUGET JL; BARBET J; CHATAL JF
    COMPARATIVE TARGETING OF HUMAN COLON-CARCINOMA MULTICELL SPHEROIDS USING ONE-STEP AND 2-STEP (BISPECIFIC ANTIBODY) TECHNIQUES
    International journal of cancer
    
    A. Devys et al., "COMPARATIVE TARGETING OF HUMAN COLON-CARCINOMA MULTICELL SPHEROIDS USING ONE-STEP AND 2-STEP (BISPECIFIC ANTIBODY) TECHNIQUES", International journal of cancer, 67(6), 1996, pp. 883-891
35. BODEN V; COLIN C; BARBET J; LEDOUSSAL JM; VIJAYALAKSHMI M
    PRELIMINARY-STUDY OF THE METAL-BINDING SITE OF AN ANTI-DTPA-INDIUM ANTIBODY BY EQUILIBRIUM BINDING IMMUNOASSAYS AND IMMOBILIZED METAL-ION AFFINITY-CHROMATOGRAPHY
    Bioconjugate chemistry
    
    V. Boden et al., "PRELIMINARY-STUDY OF THE METAL-BINDING SITE OF AN ANTI-DTPA-INDIUM ANTIBODY BY EQUILIBRIUM BINDING IMMUNOASSAYS AND IMMOBILIZED METAL-ION AFFINITY-CHROMATOGRAPHY", Bioconjugate chemistry, 6(4), 1995, pp. 373-379
36. THIMONIER J; CHAUVIN JP; BARBET J; ROCCASERRA J
    PRELIMINARY STUDIES OF AN IMMUNOGLOBULIN-M BY NEAR-FIELD MICROSCOPIES
    Journal of trace and microprobe techniques
    
    J. Thimonier et al., "PRELIMINARY STUDIES OF AN IMMUNOGLOBULIN-M BY NEAR-FIELD MICROSCOPIES", Journal of trace and microprobe techniques, 13(3), 1995, pp. 353-359
37. CHATAL JF; FAIVRECHAUVET A; BARDIES M; PELTIER P; GAUTHEROT E; BARBET J
    BIFUNCTIONAL ANTIBODIES FOR RADIOIMMUNOTHERAPY
    Hybridoma
    
    J.F. Chatal et al., "BIFUNCTIONAL ANTIBODIES FOR RADIOIMMUNOTHERAPY", Hybridoma, 14(2), 1995, pp. 125-128
38. JEAN F; BOURCIER B; LEBEC S; DELAAGE M; BARBET J
    A NOVEL PROTEIN IMMUNOASSAY WITH PREDETERMINED SPECIFICITY USING MONOCLONAL-ANTIBODIES AGAINST TRYPTIC FRAGMENTS - APPLICATION TO HIV P24 ANTIGEN
    Journal of immunological methods
    
    F. Jean et al., "A NOVEL PROTEIN IMMUNOASSAY WITH PREDETERMINED SPECIFICITY USING MONOCLONAL-ANTIBODIES AGAINST TRYPTIC FRAGMENTS - APPLICATION TO HIV P24 ANTIGEN", Journal of immunological methods, 185(1), 1995, pp. 103-114
39. MANETTI C; LEDOUSSAL JM; ROUVIER E; GRUAZGUYON A; BARBET J
    INTRACELLULAR UPTAKE AND CATABOLISM OF ANTI-IGM ANTIBODIES AND BI-SPECIFIC ANTIBODY-TARGETED HAPTEN BY B-LYMPHOMA CELLS
    International journal of cancer
    
    C. Manetti et al., "INTRACELLULAR UPTAKE AND CATABOLISM OF ANTI-IGM ANTIBODIES AND BI-SPECIFIC ANTIBODY-TARGETED HAPTEN BY B-LYMPHOMA CELLS", International journal of cancer, 63(2), 1995, pp. 250-256
40. MICHON J; MOUTEL S; BARBET J; ROMETLEMONNE JL; DEO YM; FRIDMAN WH; TEILLAUD JL
    IN-VITRO KILLING OF NEUROBLASTOMA-CELLS BY NEUTROPHILS DERIVED FROM GRANULOCYTE-COLONY-STIMULATING FACTOR-TREATED CANCER-PATIENTS USING AN ANTI-DISIALOGANGLIOSIDE ANTI-FC-GAMMA-RI BISPECIFIC ANTIBODY
    Blood
    
    J. Michon et al., "IN-VITRO KILLING OF NEUROBLASTOMA-CELLS BY NEUTROPHILS DERIVED FROM GRANULOCYTE-COLONY-STIMULATING FACTOR-TREATED CANCER-PATIENTS USING AN ANTI-DISIALOGANGLIOSIDE ANTI-FC-GAMMA-RI BISPECIFIC ANTIBODY", Blood, 86(3), 1995, pp. 1124-1130
41. THIMONIER J; CHAUVIN JP; BARBET J; ROCCASERRA J
    SCANNING-TUNNELING-MICROSCOPY OF MONOCLONAL IMMUNOGLOBULIN-G
    Microscopy microanalysis microstructures
    
    J. Thimonier et al., "SCANNING-TUNNELING-MICROSCOPY OF MONOCLONAL IMMUNOGLOBULIN-G", Microscopy microanalysis microstructures, 5(4-6), 1994, pp. 341-349
42. ROCCASERRA J; THIMONIER J; CHAUVIN JP; BARBET J
    SCANNING-TUNNELING-MICROSCOPY OF PROTEINS OF THE IMMUNOGLOBULIN SUPERFAMILY
    Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena
    
    J. Roccaserra et al., "SCANNING-TUNNELING-MICROSCOPY OF PROTEINS OF THE IMMUNOGLOBULIN SUPERFAMILY", Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena, 12(3), 1994, pp. 1490-1493
43. PELTIER P; BARDET S; CHETANNEAU A; BARBET J; DELAAGE M; CHATAL JF
    SCINTIGRAPHIC IMAGING OF LIVER METASTASES (LM) USING BISPECIFIC ANTICARCINOEMBRYONIC ANTIGEN (CEA) ANTI-DTPA-INDIUM IMMUNOCONJUGATE AND DI-DTPA-IN-111/
    The Journal of nuclear medicine
    
    P. Peltier et al., "SCINTIGRAPHIC IMAGING OF LIVER METASTASES (LM) USING BISPECIFIC ANTICARCINOEMBRYONIC ANTIGEN (CEA) ANTI-DTPA-INDIUM IMMUNOCONJUGATE AND DI-DTPA-IN-111/", The Journal of nuclear medicine, 35(5), 1994, pp. 160000055-160000055
44. CHETANNEAU A; BARBET J; PELTIER P; BERNARD AM; LEDOUSSAL JM; GRUAZGUYON A; BOURGUET P; DELAAGE M; CHATAL JF
    IMAGING HUMAN COLORECTAL-CANCER RECURRENCE WITH IN-111-LABELED BIVALENT DTPA HAPTEN AND DUAL-SPECIFICITY MONOCLONAL-ANTIBODY CONJUGATE
    The Journal of nuclear medicine
    
    A. Chetanneau et al., "IMAGING HUMAN COLORECTAL-CANCER RECURRENCE WITH IN-111-LABELED BIVALENT DTPA HAPTEN AND DUAL-SPECIFICITY MONOCLONAL-ANTIBODY CONJUGATE", The Journal of nuclear medicine, 35(5), 1994, pp. 160000055-160000055
45. CHETANNEAU A; BARBET J; PELTIER P; LEDOUSSAL JM; GRUAZGUYON A; BERNARD AM; RESCHE I; ROUVIER E; BOURGUET P; DELAAGE M; CHATAL JF
    PRETARGETED IMAGING OF COLORECTAL-CANCER RECURRENCES USING AN IN-111-LABELED BIVALENT HAPTEN AND A BISPECIFIC ANTIBODY CONJUGATE
    Nuclear medicine communications
    
    A. Chetanneau et al., "PRETARGETED IMAGING OF COLORECTAL-CANCER RECURRENCES USING AN IN-111-LABELED BIVALENT HAPTEN AND A BISPECIFIC ANTIBODY CONJUGATE", Nuclear medicine communications, 15(12), 1994, pp. 972-980
46. BARBET J; GARVIN A; THIMONIER J; CHAUVIN JP; ROCCASERRA J
    SCANNING-TUNNELING-MICROSCOPY OF COLLOIDAL GOLD BEADS
    Ultramicroscopy
    
    J. Barbet et al., "SCANNING-TUNNELING-MICROSCOPY OF COLLOIDAL GOLD BEADS", Ultramicroscopy, 50(3), 1993, pp. 355-363
47. PELTIER P; CURTET C; CHATAL JF; LEDOUSSAL JM; DANIEL G; AILLET G; GRUAZGUYON A; BARBET J; DELAAGE M
    RADIOIMMUNODETECTION OF MEDULLARY-THYROID CANCER USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER
    The Journal of nuclear medicine
    
    P. Peltier et al., "RADIOIMMUNODETECTION OF MEDULLARY-THYROID CANCER USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER", The Journal of nuclear medicine, 34(8), 1993, pp. 1267-1273
48. LEDOUSSAL JM; CHETANNEAU A; GRUAZGUYON A; MARTIN M; GAUTHEROT E; LEHUR PA; CHATAL JF; DELAAGE M; BARBET J
    BISPECIFIC MONOCLONAL ANTIBODY-MEDIATED TARGETING OF AN INDIUM-111-LABELED DTPA DIMER TO PRIMARY COLORECTAL TUMORS - PHARMACOKINETICS, BIODISTRIBUTION, SCINTIGRAPHY AND IMMUNE-RESPONSE
    The Journal of nuclear medicine
    
    J.M. Ledoussal et al., "BISPECIFIC MONOCLONAL ANTIBODY-MEDIATED TARGETING OF AN INDIUM-111-LABELED DTPA DIMER TO PRIMARY COLORECTAL TUMORS - PHARMACOKINETICS, BIODISTRIBUTION, SCINTIGRAPHY AND IMMUNE-RESPONSE", The Journal of nuclear medicine, 34(10), 1993, pp. 1662-1671
49. BARBET J; LEDOUSSAL JM; GRUAZGUYON A; MARTIN M; GAUTHEROT E; DELAAGE M
    COMPUTER CALCULATION OF MULTIPLE BINDING EQUILIBRIUM ISOTHERMS - APPLICATION TO THE BINDING OF BIVALENT LIGANDS TO ANTIBODIES INTERACTING WITH CELL-SURFACE FC-RECEPTORS
    Journal of theoretical biology
    
    J. Barbet et al., "COMPUTER CALCULATION OF MULTIPLE BINDING EQUILIBRIUM ISOTHERMS - APPLICATION TO THE BINDING OF BIVALENT LIGANDS TO ANTIBODIES INTERACTING WITH CELL-SURFACE FC-RECEPTORS", Journal of theoretical biology, 165(3), 1993, pp. 321-340